登入選單
返回Google圖書搜尋
The Cost of Cancer Treatment Study's Design and Methods
註釋Traditionally, the cost of conducting cancer clinical trials has been supported by a combination of research sponsors, institutions, and third-party payers. However, health insurers and other payers are increasingly reluctant to reimburse for direct patient care provided as part of a clinical trial. These policies--driven in part by a perception that patients enrolled in trials incur substantial additional costs--might impede efforts to enroll patients in clinical trials. Yet there is little evidence regarding the costs of treating patients in clinical trials.